元阿萍,刘超,黄霞,王秀菊,余学端.熟地多糖联合康力龙治疗慢性再生障碍性贫血34例[J].中国中西医结合杂志,1998,(6):351-353 |
熟地多糖联合康力龙治疗慢性再生障碍性贫血34例 |
Treatment of 34 Cases of Chronic Aplastic Anemia Using Prepared Rehmannia Polysaccharide Associated with Stanozolol |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 熟地多糖 康力龙 再生障碍性贫血 |
英文关键词:prepared Rehmannia polysaccharide stanozolol chronic aplastic anemia |
基金项目: |
作者 | 单位 | 元阿萍 | Yuan Aping, Liu Chao, Huang Xia, et al The Second Affiliated Hospital of Henan Medical University, Zhengzhou (450003 | 刘超 | Yuan Aping, Liu Chao, Huang Xia, et al The Second Affiliated Hospital of Henan Medical University, Zhengzhou (450003 | 黄霞 | Yuan Aping, Liu Chao, Huang Xia, et al The Second Affiliated Hospital of Henan Medical University, Zhengzhou (450003 | 王秀菊 | Yuan Aping, Liu Chao, Huang Xia, et al The Second Affiliated Hospital of Henan Medical University, Zhengzhou (450003 | 余学端 | Yuan Aping, Liu Chao, Huang Xia, et al The Second Affiliated Hospital of Henan Medical University, Zhengzhou (450003 |
|
摘要点击次数: 1362 |
全文下载次数: 920 |
中文摘要: |
目的 :探讨熟地多糖治疗慢性再生障碍性贫血 (慢性再障 )的疗效及副作用。方法 :用熟地多糖口服液联合康力龙治疗慢性再障 3 4例 ,疗程 3个月 ,同时和 1 7例单用康力龙的病例作对比。结果 :治疗组总有效率为 85 3 % ,对照组为 5 8 8% ,两组比较有显著性差异 (P<0 0 5 )。治疗组症状改善明显较对照组快 ,症状积分两组比较有显著性差异 (P <0 0 1 )。治疗组治疗 3个月后外周血细胞明显升高 ,和治疗前比较有显著性差异 (P <0 0 1 ) ,治疗中未发现熟地多糖有任何毒副作用。结论 :熟地多糖和康力龙联合治疗慢性再障能起到相加作用 ,加速症状的改善 ,提高疗效 ,不增加副作用。 |
英文摘要: |
Objective: To investigate the effect and side effect of prepared Rehmannia polysaccharide (PRP) associated with stanozolol in treating chronic aplastic anemia (CAA). Methods: Thirty four cases of CAA were treated by PRP liquid associated with stanozolol, course of 3 week treatment, and control group (17 cases of CAA) was treated by stanozolol alone. Results: Effective rate was 85.3% in treatment group, and that of control group was 58.8%, there was significant difference between them (P<0 05). Symptom remission of treatment group was earlier than that of control group, symptom scoring between two groups, the difference was highly significant (P<0 01). Blood cell had a distinct elevation after treatment with PRP associated with stanozolol, and had a significant difference in comparing with pre treatment in treatment group (P<0 01). Side effect of PRP was not found during treatment of CAA. Conclusions: PRP associated with stanozolol to treat CAA has an additional effect, it can accelerate symptom remission without any additional side effect. |
关闭 |
|
|
|